Role of the gut microbiota in the development and function of lymphoid cells - PubMed (original) (raw)

Review

Role of the gut microbiota in the development and function of lymphoid cells

Nobuhiko Kamada et al. J Immunol. 2013.

Abstract

Mammals are colonized by large numbers of microorganisms, including trillions of bacteria, most of which live in the intestinal tract. These indigenous microorganisms that inhabit the body of humans and animals are referred collectively to as the microbiota. Accumulating evidence indicates that the microbiota regulates the development and/or function of different types of immune cells in the intestine. For example, the microbiota drives homeostatic, pathogenic, and regulatory T cell immune responses that contribute to tissue homeostasis, but also can promote disease. The gut microbes also facilitate IgA responses, which in turn regulate the composition and function of the gut microbiota. Thus, the reciprocal regulation of the gut microbiota and the host immune system may influence the balance between homeostasis and disease in the intestine.

PubMed Disclaimer

Conflict of interest statement

Disclosures:

The authors have no conflicting financial interests.

Figures

Figure 1

Figure 1. Gut microbiota drive homeostatic, pathogenic and regulatory lymphocyte immunity

The gut microbiota directly or indirectly regulates the function of TCRγδ T cells. In turn, TCRγδ T cells regulate the microbiota through induction of the anti-microbial peptide RegIIIγ. The microbiota positively or negatively regulate the differentiation and/or function of RORγt+ ILCs. The microbiota stabilize the expression of RORγt+ in ILCs through induction of IL-7. The absence of microbiota-induced IL-7 signaling or the presence of IL-12 and IL-15 facilitates the conversion of RORγt+ ILCs into RORγt− IFN-γ-producing pathogenic ILCs. Segmented filamentous bacteria (SFB) promote the differentiation of Th17 cells in the gut. Steady-state Th17 cells produce IL-17, IL-22 and IL-10 and may play an homeostatic role in the gut. IL-23, IL-12, IL-1β, TGF-β3 induce conversion of homeostatic Th17 cells towards pathogenic, IFN-γ-producing Th17 cells that facilitate intestinal inflammation. Certain subsets of commensal microbiota, such as Clostridium clusters XIVa and IV and Bacteroides fragilis, promote the development and functional maturation of Foxp3+Helios− inducible Tregs. Foxp3+ iTregs suppress the expansion of Th17 cells as well as their conversion into IFN-γ-producing Th17 cells.

Similar articles

Cited by

References

    1. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010;10:159–169. - PubMed
    1. Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annu Rev Immunol. 2012;30:759–795. - PMC - PubMed
    1. Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell. 2010;140:845–858. - PubMed
    1. Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008;4:337–349. - PMC - PubMed
    1. Atarashi K, Nishimura J, Shima T, Umesaki Y, Yamamoto M, Onoue M, Yagita H, Ishii N, Evans R, Honda K, Takeda K. ATP drives lamina propria T(H)17 cell differentiation. Nature. 2008;455:808–812. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources